Tag Archives: SPM

AFT Features, PRNews, Travel & Wellness

adidas and Wanderlust Break the GUINNESS WORLD RECORDS(TM) Title for Most people doing yoga in pairs

NEW YORK, Sept. 12, 2017 /PRNewswire/ — On Sunday, September 10th adidas and Wanderlust broke the official GUINNESS WORLD RECORDS Title for Most people doing yoga in pairs at the Wanderlust 108 Brooklyn event in Prospect Park. Led by yoga instructors Elena Brower and Lauren Imparato, over 2500 people participated in the record breaking attempt that lasted approximately 10 minutes. The partner flow included three poses — Thick Tree, Supported Chair and Supported Seat Twist.


adidas and Wanderlust Break the GUINNESS WORLD RECORDS Title for Most People Doing Yoga in Pairs – Sept 10, 2017

adidas and Wanderlust Break the GUINNESS WORLD RECORDS Title for Most People Doing Yoga in Pairs – Sept 10, 2017

“The partnership with Wanderlust allows us to create new and exciting opportunities. Breaking a GUINNESS WORLD RECORDS title was a unique way for us to bring people together and celebrate the largest Wanderlust event in the world,” said Alison Stewart, Senior Director for adidas Women’s.

adidas and Wanderlust share a vision of holistic, high-touch experiences that create community around sport and mindful living. Wanderlust’s transformative events attract some of the world’s most versatile and committed fitness and healthy-lifestyle devotees, including trainers, instructors and attendees. A Wanderlust 108 is full day celebration in support of the mindful movement, featuring a triathlon of three intentional activities in a local park: a 5K run, an outdoor yoga flow class and a guided meditation.

“Wanderlust’s mission is to help people to find their true north, and part of that is making yoga, meditation and mindfulness practice something that’s accessible, attainable, community-focused and fun. The idea of getting grounded while also setting a world record with a friend was immediately appealing, and we’re thrilled to be working with adidas and Guinness to make it happen,” said Sean Hoess, co-CEO of Wanderlust.

For additional images and information, please refer to the media contacts above.  For more information about Wanderlust events please visit www.wanderlust.com. To shop the adidas x Wanderlust Co-Branded apparel collection please visit www.adidas.com.  

About the adidas Group
 adidas is a global leader in the sporting goods industry. A designer and developer of athletic and lifestyle footwear, apparel and accessories, adidas has the mission to be the best sports brand in the world. Headquartered in Herzogenaurach, Germany and Portland, Ore., adidas employs more than 60,000 people across the globe and generated sales of EUR19 billion in 2016.

About Wanderlust:
Wanderlust Holdings, LLC is a global yoga lifestyle company founded in 2009. Our mission is to help you find your true north — to live a healthy and inspired live.  Wanderlust’s events encompass Wanderlust Festival, the largest multi-day yoga and music festivals in the world and Wanderlust 108, a one-day “mindful triathlon” taking place in urban parks across the world. In 2012, we opened the first Wanderlust Yoga studio, a re-imagination of the yoga studio experience and began offering Wanderlust Teacher Training, a yoga teacher-training program inspired by the Wanderlust festival experience. In 2015, we launched Wanderlust TV, a media platform connecting viewers with inspirational teachers and wellness experts and Wanderlust Hollywood, a 10,000 square foot center in Los Angeles, CA offering yoga and meditation classes, a world-class organic restaurant, and a full-featured performance venue.

Photo – https://mma.prnewswire.com/media/554627/adidas_and_Wanderlust_GUINNESS_WORLD_RECORDS.jpg
Photo – https://mma.prnewswire.com/media/554628/adidas_and_Wanderlust_GUINNESS_WORLD_RECORDS_2.jpg

PRNews

Ganeden Brings Probiotic Exhibit and Expertise to Fi Asia

Global leader will discuss probiotic formulation trends, science updates and product launches

CLEVELAND, Aug. 29, 2017 /PRNewswire/ — As probiotic fortification continues to gain momentum around the world, probiotic leader Ganeden is expanding its presence at additional food and beverage events globally—including in Asia. This September, experts from the top probiotic ingredient supplier will be attending Food Ingredients Asia (Fi Asia) in Bangkok. Team members based locally and from the U.S. headquarters will be on site to discuss new probiotic research, offer insight into upcoming product launches and help manufacturers explore innovative probiotic formulations beyond traditional dairy applications.

Ganeden has become a driving force in the probiotic space internationally, helping hundreds of manufacturers use probiotic technology in their products in innovative ways—including many in Asia. As a global leader, the science-driven company is knowledgeable on probiotic trends around the world, including consumer demand, research advancements and innovative options for probiotic fortification beyond the dairy case. Experts can assist in probiotic ingredient selection, including providing details on strain specificity, study requirements and health benefits.

“There are tremendous growth opportunities for probiotic technologies in the Asian market, and Fi Asia gives us a chance to provide expertise on how health benefits can be added to products to drive consumer interest and purchases,” said Stephen Quinn, business and regulatory director for Asia at Ganeden. “We plan to meet with industry leaders and innovators to demonstrate how functional ingredients can benefit end-users and grow business. There is a strong tradition of probiotics in Asia, but nearly all of it is in the supplement and dairy categories, so having a chance to provide the same health benefits in other food and beverage applications is exciting for manufacturers and their customers.”

Ganeden is best known for GanedenBC30® (Bacillus coagulans GBI-30, 6086), its patented and shelf stable probiotic ingredient that remains viable through most manufacturing processes, shelf life and gastric transit—allowing it to be fortified into almost any food or beverage product. Years of ongoing studies confirm the strain’s safety, digestive and immune support, and protein utilization benefits. And because GanedenBC30 has been shown to survive 10X more effectively than yogurt cultures, it has become one of the top ingredient choices for probiotic benefits in both refrigerated and non-refrigerated products.

During the show, Ganeden will also introduce the newest addition to its ingredient portfolio—Staimune™. The new ingredient uses the inactivated cells of GanedenBC30, which have been shown to support immune health. Staimune’s ease of formulation opens up new opportunities in immune-focused, functional foods and beverages which involve processes too harsh for live probiotics.

To meet with probiotic experts at the Fi Asia show, contact Ganeden or visit booth #F34. For more information on the probiotic company, including its ingredient portfolio, research and international presence, visit GandedenProbiotics.com.

About Ganeden:

Ganeden® is at the forefront of probiotic research and product development with an extensive library of published studies and more than 135 patents for probiotic technologies in the supplement, food, beverage, animal health, sports nutrition and personal care ingredients markets. Ganeden is best known for GanedenBC30®, its patented, FDA GRAS, highly stable probiotic ingredient. Through the fermentation process of GanedenBC30, Ganeden developed Bonicel®, the first science-backed, probiotic-derived, personal care ingredient shown to dramatically reduce signs of aging. Ganeden’s newest ingredient, Staimune™ is a patented probiotic technology comprising of inactivated GanedenBC30 which has been shown to have immune benefits. For more information about Ganeden and licensing opportunities visit GanedenProbiotics.com. 

PRNews

Young Living Essential Oils Promotes Lauren Walker to Chief Supply Officer

-Walker Leads the Sourcing Pillar of Young Living’s Seed to Seal Program-

LEHI, Utah, Aug. 18, 2017 /PRNewswire/ — Young Living Essential Oils, the world leader in essential oils, today announced that it has promoted Lauren Walker to the role of Chief Supply Officer. In her time with Young Living, she and her team have further implemented rigorous sourcing standards while also streamlining manufacturing, warehousing and fulfillment operations.

“Lauren embraces Young Living’s passion for being stewards of the earth and has been a driving force in ensuring that the sourcing, manufacturing and shipping components of our business all operate under that mindset,” said Jared Turner, Young Living Chief Operating Officer. “Her experience and expertise in project management, manufacturing, and supply chain gained throughout her career has been a great addition to our strong executive team.”

Walker leads the sourcing pillar of Young Living’s Seed to Seal program (Sourcing, Science and Standards), that governs how we obtain our products — whether from our corporate-owned farms, partner farms, or Seed to Seal-certified supplier. The sourcing pillar is also a major part of how we verify, through internal and third-party tracking, that the superior essential oils and premium ingredients in our products such as foods, skin care, and supplements were produced and manufactured according to industry best practices and our own high standards.

“We have an obligation to provide our customers with the highest quality products and the best customer experience, and we do that by having effective processes in place,” said Walker. “I’m proud that our team has assessed the whole supply chain of an oil and refined or established processes that help us provide the best products and services to our customers.”                   

Throughout her three-decade career with high-profile international companies, Walker has established herself as a leader and an innovator in streamlining global systems. After completing her engineering degree, she worked for Xerox as an engineer, followed by 10 years with Procter & Gamble in supply chain, manufacturing/technical operations, and quality. She also worked for seven years with Johnson & Johnson as a plant manager and as Program Manager of their Oral Care franchise. Prior to joining Young Living in 2016, she was Vice President of Manufacturing at Amway, where she was responsible for manufacturing across all product lines: nutrition, home care, personal care, beauty care, durable goods, and paper products.

In addition to her extensive experience, Walker has been a keynote speaker for American Manufacturing Strategies Summit and Front End Innovations Conference, is a Lean Six Sigma Project Champion in Manufacturing, and is Green Belt Certified. She holds a degree in engineering from Union College in New York. Lauren currently serves on the Board of Directors for the Salt Lake Chamber.

About Young Living Essential Oils
Young Living Essential Oils, LC, is the world leader in essential oils, with a strict Seed to Seal® process that produces pure essential oil products for every individual, family, and lifestyle. This process ensures that all products are genuine, free of synthetic chemicals, and pure. This commitment stems from the company’s more than 20 years of stewardship toward the earth and its people. For more information, visit YoungLiving.com.

Media Contact:
For media inquiries, please contact prinquiries@youngliving.com.

Photo – https://mma.prnewswire.com/media/546503/Lauren_Walker_Young_Living_Essential_Oils.jpg
Logo – https://mma.prnewswire.com/media/323110/Young_Living_Essential_Oils_Logo.jpg

PRNews

MyDx Files Complaint Against Former Chief Operating Officer, Protects Unique AeroDx Diagnostic Platform and Addresses Toxic Financier’s Unauthorized Conversion

SAN DIEGO, July 18, 2017 /PRNewswire/ — MyDx, Inc. (OTCQB:MYDX), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer initially designed for cannabis professionals and retail consumers to measure the chemicals in cannabis and track their feedback on how each sample is impacting their physiology, today announced that all previously reported variable toxic debts have been satisfied through the unauthorized conversion of the Crown Bridge note and has also filed a lawsuit against its former COO and other defendants who have attempted to create a competitive advantage with its anticipated product launch of its air quality sensor: AeroDx®.


MyDx 2.0 Analyzer with CannaDx and AeroDx Sensor Compatibility

Lawsuit to Protect Unique AeroDx Diagnostic Platform
On July 14, 2017, the Company and its Chief Executive Officer, Daniel Yazbeck, filed a complaint in Superior Court of California against a series of Defendants who have allegedly engaged in unfair business practices, made false statements about the Company, its products, and Mr. Yazbeck at investor events and on online investor platforms.  There can be no assurance about the results or on the outcome of the lawsuit, however, the company took aggressive steps it felt were necessary to protect its business and its shareholders.

AeroDx®: MyDx’s Air Quality Sensor
AeroDx Sensors are the first of three anticipated versatile sensors to be launched into the market and represents the first versatile sensor to be used with the new release of the MyDx 2.0 Analyzer launched in May of this year.  AeroDx is expected to measure key air quality parameters for cannabis and non-cannabis consumers, to be interchanged seamlessly with the CannaDx Sensors. Once AeroDx Sensors are inserted into the MyDx Device, the device becomes an air quality tester with the ability to detect Volatile Organic Compounds (VOC’s) such as Formaldehyde, Butane, Toluene, Methane, Benzene and other harmful chemicals, such as Carbon Dioxide, present in the air. It can also monitor temperature and humidity, which can aid in preventing mold and germ growth. The company is also in the process of customizing the sensor in order to ensure air quality and control in cannabis growth facilities as well offer a test for residual solvents in cannabis oils.

Addressing Remaining Toxic Variable Convertible Debt on Balance Sheet
 On April 30, 2017, the Company sent a payoff demand to Crown Bridge Partners, LLC as required under the terms of the loan Agreement.  The Company agreed to repay, in full, the remaining variable toxic convertible note on its balance sheet prior to the prepayment deadline. Crown Bridge acknowledged the request and despite the Company and its counsel’s repeated payoff request, on July 3, 2017, Crown converted $36,749.04 (the entire amount due pursuant to the Note, including penalties and interest) into 14,699,616 shares of the Company’s common stock. In light of the Company’s notification and Crown Bridge’s acknowledgment required under the terms of the loan Agreements, Crown Bridge executed the conversion and the Company alleges it breached the terms of the Note. The Company will continue to evaluate its rights and determine the best course of action to advance the interests of its shareholders.

As of July 17, 2017, all previously reported variable rate toxic financing has been fully paid off.

About MyDx, Inc.
 MyDx, Inc. (OTCQB: MYDX) is a chemical detection and sensor technology company based in San Diego, California whose mission is to help people Trust & Verify® what they put into their minds and bodies. The Company developed MyDx®, a patented, affordable portable analyzer that provides real-time chemical analysis and fits in the palm of the user’s hand. The multi-use MyDx analyzer leverages over a decade of established chemical detection technology to measure chemicals of interest. The Company owns a substantial and growing intellectual property portfolio of patents covering its technology. The MyDx AquaDx®, OrganaDx(TM) and CannaDx(TM) sensors are now commercialized, and the AeroDx® application is next in line. All sensors will be compatible with a MyDx App that empowers consumers to live a healthier life by revealing the chemical composition of what they eat, drink and inhale. For more information, please visit www.mydxlife.com.

Forward-Looking Statements
This news release contains “forward-looking statements” as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as “may,” “will,” “expect,” “believe,” “anticipate,” “estimate,” “intends,” “goal,” “objective,” “seek,” “attempt,” or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at http://ir.cdxlife.com/all-sec-filings or www.sec.gov. MyDx is not considered a medical device.  Consumers should be advised that any claims regarding the medical benefits of cannabis are still under research and until approved by the FDA or any other relevant international regulatory body, are considered anecdotal in nature. 

Investor Contact:
MyDx Shareholder Communications
800.814.4550 ext. 4
ir@cdxlife.com

Photo – http://mma.prnewswire.com/media/536158/MyDx_Inc_Analyzer_with_CannaDx.jpg 

Source: MyDx, Inc.